NB-360 (NB360) is a novel, potent, orally bioavailable and brain penetrant inhibitor of beta-secretase BACE1/BACE2 with anti-AD (Alzheimer's disease) activity. It inhibits BACE1/2 with IC50 of 5 nM and 6 nM, respectively.